Archer Investment Corporation’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,000
| Closed | -$1.41K | – | 1032 |
|
|
2023
Q2 | $1.41K | Hold |
1,000
| – | – | ﹤0.01% | 884 |
|
|
2023
Q1 | $1.5K | Hold |
1,000
| – | – | ﹤0.01% | 754 |
|
|
2022
Q4 | $1.17K | Hold |
1,000
| – | – | ﹤0.01% | 744 |
|
|
2022
Q3 | $1.13K | Hold |
1,000
| – | – | ﹤0.01% | 721 |
|
|
2022
Q2 | $1.58K | Hold |
1,000
| – | – | ﹤0.01% | 702 |
|
|
2022
Q1 | $1.54K | Hold |
1,000
| – | – | ﹤0.01% | 715 |
|
|
2021
Q4 | $2.45K | Hold |
1,000
| – | – | ﹤0.01% | 676 |
|
|
2021
Q3 | $2.52K | Hold |
1,000
| – | – | ﹤0.01% | 636 |
|
|
2021
Q2 | $2.85K | Hold |
1,000
| – | – | ﹤0.01% | 522 |
|
|
2021
Q1 | $2.35K | Hold |
1,000
| – | – | ﹤0.01% | 668 |
|
|
2020
Q4 | $1.76K | Hold |
1,000
| – | – | ﹤0.01% | 639 |
|
|
2020
Q3 | $937 | Hold |
1,000
| – | – | ﹤0.01% | 604 |
|
|
2020
Q2 | $870 | Hold |
1,000
| – | – | ﹤0.01% | 608 |
|
|
2020
Q1 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 564 |
|
|
2019
Q4 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 558 |
|
|
2019
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 473 |
|
|
2019
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 462 |
|
|
2019
Q1 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 475 |
|
|
2018
Q4 | $1K | Buy |
+1,000
| New | +$1K | ﹤0.01% | 444 |
|